Secukinumab Biosimilar(Rophibio)
N/A
Report date: 2024/07/31 15:37:50
Base Information
Drug NameSecukinumab Biosimilar(Rophibio)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRophibio Inc
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksN/A